Julie Garon

912 total citations
22 papers, 601 citations indexed

About

Julie Garon is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Julie Garon has authored 22 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Epidemiology. Recurrent topics in Julie Garon's work include Viral gastroenteritis research and epidemiology (11 papers), Viral Infections and Immunology Research (10 papers) and Vaccine Coverage and Hesitancy (8 papers). Julie Garon is often cited by papers focused on Viral gastroenteritis research and epidemiology (11 papers), Viral Infections and Immunology Research (10 papers) and Vaccine Coverage and Hesitancy (8 papers). Julie Garon collaborates with scholars based in United States, Switzerland and Zimbabwe. Julie Garon's co-authors include Walter A. Orenstein, Katherine Seib, Ananda S Bandyopadhyay, Manish Patel, Michel Zaffran, Lee M. Hampton, Stephanie Shendale, Lisa Menning, Margaret Farrell and Jennifer Rubin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and PLoS Medicine.

In The Last Decade

Julie Garon

22 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Garon United States 10 422 366 180 109 51 22 601
Hiromasa Okayasu Switzerland 15 326 0.8× 319 0.9× 117 0.7× 72 0.7× 40 0.8× 25 472
Sonia Resik Cuba 15 358 0.8× 321 0.9× 236 1.3× 36 0.3× 59 1.2× 43 636
Pradeep Malankar Switzerland 10 365 0.9× 364 1.0× 136 0.8× 30 0.3× 57 1.1× 11 495
M. L. Thoms United States 9 402 1.0× 368 1.0× 315 1.8× 52 0.5× 55 1.1× 9 655
Wendy Sessions United States 11 313 0.7× 230 0.6× 662 3.7× 70 0.6× 105 2.1× 17 826
Simona Zipursky United States 11 227 0.5× 163 0.4× 87 0.5× 89 0.8× 22 0.4× 19 344
John Kofi Odoom Ghana 11 273 0.6× 224 0.6× 155 0.9× 14 0.1× 42 0.8× 44 439
Fem Julia Paladin Philippines 12 308 0.7× 208 0.6× 145 0.8× 17 0.2× 43 0.8× 16 445
Allison Waters Ireland 14 222 0.5× 59 0.2× 242 1.3× 34 0.3× 50 1.0× 39 517
A. J. Williams United States 7 916 2.2× 284 0.8× 213 1.2× 13 0.1× 84 1.6× 9 1.0k

Countries citing papers authored by Julie Garon

Since Specialization
Citations

This map shows the geographic impact of Julie Garon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Garon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Garon more than expected).

Fields of papers citing papers by Julie Garon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Garon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Garon. The network helps show where Julie Garon may publish in the future.

Co-authorship network of co-authors of Julie Garon

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Garon. A scholar is included among the top collaborators of Julie Garon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Garon. Julie Garon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Doshi, Reena H., Rebecca M. Casey, Nedghie Adrien, et al.. (2022). Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020. SHILAP Revista de lepidopterología. 2(4). e0000130–e0000130. 9 indexed citations
3.
4.
Casey, Rebecca M., et al.. (2021). National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned. Vaccine. 40. A10–A16. 17 indexed citations
5.
Suthar, Amitabh B., et al.. (2021). Coronavirus Disease Case Definitions, Diagnostic Testing Criteria, and Surveillance in 25 Countries with Highest Reported Case Counts. Emerging infectious diseases. 28(1). 148–156. 13 indexed citations
6.
7.
Daugherty, Michael, Alan R. Hinman, Stephen L. Cochi, et al.. (2019). The Global Vaccine Action Plan – insights into its utility, application, and ways to strengthen future plans. Vaccine. 37(35). 4928–4936. 9 indexed citations
8.
Duhaime, Gérard, et al.. (2018). Le Nouveau Régime: Épisode de la Mise en Oeuvre de Nutrition Nord Canada au Nunavik, 2011-2013. 78. 1 indexed citations
9.
Dolan, Samantha, Manish Patel, Lee M. Hampton, et al.. (2017). Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally. The Journal of Infectious Diseases. 216(suppl_1). S152–S160. 11 indexed citations
10.
Garon, Julie & Manish Patel. (2017). The polio endgame: rationale behind the change in immunisation. Archives of Disease in Childhood. 102(4). 362–365. 3 indexed citations
11.
Farrell, Margaret, Lisa Menning, Julie Garon, et al.. (2016). Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines—Lessons Learned From the Global Perspective. The Journal of Infectious Diseases. 216(suppl_1). S183–S192. 22 indexed citations
12.
Garon, Julie & Walter A. Orenstein. (2016). Improving the Science of Measles Prevention—Will It Make for a Better Immunization Program?. PLoS Medicine. 13(10). e1002145–e1002145. 1 indexed citations
13.
Hampton, Lee M., Margaret Farrell, Lisa Menning, et al.. (2016). Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine — Worldwide, 2016. MMWR Morbidity and Mortality Weekly Report. 65(35). 934–938. 156 indexed citations
14.
Farrell, Margaret, Lee M. Hampton, Stephanie Shendale, et al.. (2016). Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016. The Journal of Infectious Diseases. 216(suppl_1). S193–S201. 9 indexed citations
15.
Garon, Julie, Walter A. Orenstein, & T. Jacob John. (2016). The Need and Potential of Inactivated Poliovirus Vaccine.. PubMed. 53 Suppl 1. S2–S6. 2 indexed citations
16.
Garon, Julie & Walter A. Orenstein. (2015). Understanding the host–pathogen interaction saves lives: lessons from vaccines and vaccinations. Current Opinion in Immunology. 36. 8–13. 3 indexed citations
17.
Flahault, Antoine, et al.. (2015). Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013–14: a ‘natural experiment’. International Journal of Public Health. 60(7). 765–766. 1 indexed citations
18.
Garon, Julie, Stephen L. Cochi, & Walter A. Orenstein. (2015). The Challenge of Global Poliomyelitis Eradication. Infectious Disease Clinics of North America. 29(4). 651–665. 20 indexed citations
19.
Patel, Manish, Simona Zipursky, Walt Orenstein, Julie Garon, & Michel Zaffran. (2015). Polio endgame: the global introduction of inactivated polio vaccine. Expert Review of Vaccines. 14(5). 749–762. 53 indexed citations
20.
Bandyopadhyay, Ananda S, Julie Garon, Katherine Seib, & Walter A. Orenstein. (2015). Polio Vaccination: Past, Present and Future. Future Microbiology. 10(5). 791–808. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromasa Okayasu Breakdown of academic impact, for papers by Sonia Resik Breakdown of academic impact, for papers by Pradeep Malankar Breakdown of academic impact, for papers by M. L. Thoms Breakdown of academic impact, for papers by Wendy Sessions Breakdown of academic impact, for papers by Simona Zipursky Breakdown of academic impact, for papers by John Kofi Odoom Breakdown of academic impact, for papers by Fem Julia Paladin Breakdown of academic impact, for papers by Allison Waters Breakdown of academic impact, for papers by A. J. Williams
Rankless by CCL
2026